These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23031155)

  • 1. Overlapping spironolactone dosing in primary aldosteronism and resistant essential hypertension.
    Handler J
    J Clin Hypertens (Greenwich); 2012 Oct; 14(10):732-4. PubMed ID: 23031155
    [No Abstract]   [Full Text] [Related]  

  • 2. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
    Kremer D; Beevers DG; Brown JJ; Davies DL; Ferriss JB; Fraser R; Lever AF; Robertson JI
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():213s-8. PubMed ID: 4361398
    [No Abstract]   [Full Text] [Related]  

  • 3. [Properties and indications of potassium-sparing diuretics].
    Rorive G; Krzesinski JM
    Rev Med Liege; 1986 May; 41(9):330-6. PubMed ID: 3523669
    [No Abstract]   [Full Text] [Related]  

  • 4. [The clinical spectrum of potassium-sparing diuretics].
    Greminger P; Suter PM
    Praxis (Bern 1994); 1997 Apr; 86(14):556-60. PubMed ID: 9198849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone for all hypertensive patients?
    Rosendorff C
    J Hypertens; 2010 Jan; 28(1):13-4. PubMed ID: 20016304
    [No Abstract]   [Full Text] [Related]  

  • 6. Double hit! A unique case of resistant hypertension.
    DeCarlo KE; Agrawal N
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29275380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosteronism with elevated active renin concentration: Primary versus secondary? Importance of follow-up for the diagnosis.
    Heras Benito M; Fernández-Reyes Luis MJ; Rodríguez Gómez MA
    Nefrologia (Engl Ed); 2019; 39(1):102-103. PubMed ID: 30104095
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism.
    Ichikawa S; Tajima Y; Sakamaki T; Matsuo H; Kogure M; Hirano Y; Yagi S; Murata K
    Jpn Circ J; 1984 Nov; 48(11):1184-96. PubMed ID: 6502914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of primary and secondary hyperaldosteronism.
    Br Med J; 1969 Aug; 3(5668):427-8. PubMed ID: 5811648
    [No Abstract]   [Full Text] [Related]  

  • 10. Endothelin-1 and adrenomedullin plasma levels after exposure to fludrocortisone, dexamethasone, and spironolactone.
    Vogt S; Winkler E; Hermsen D; Schott M; Schinner S; Scherbaum WA; Willenberg HS
    Clin Exp Hypertens; 2012; 34(8):582-7. PubMed ID: 22559244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aldosterone antagonists--first choice in resistant hypertension].
    Holzgreve H
    MMW Fortschr Med; 2016 Apr; 158(7):65-6. PubMed ID: 27071591
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antikaliuretic agents].
    Esch I
    Internist (Berl); 1971 Aug; 12():Suppl:352-6. PubMed ID: 4937775
    [No Abstract]   [Full Text] [Related]  

  • 13. [Normoaldosterone spironolactone sensitive hypertension--a case report].
    Krysiak R; Okopień B; Herman ZS
    Pol Arch Med Wewn; 2005 Oct; 114(4):978-81. PubMed ID: 16789524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 7: Medical treatment of primary aldosteronism.
    Pechère-Bertschi A; Herpin D; Lefebvre H
    Ann Endocrinol (Paris); 2016 Jul; 77(3):226-34. PubMed ID: 27315759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary hyperaldosteronism].
    Plouin PF; Massien-Simon C
    Rev Prat; 1998 Apr; 48(7):749-53. PubMed ID: 11767370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spironolactone in essential hypertension associated with abnormal aldosterone regulation and in Conn's syndrome (author's transl)].
    Wambach G; Helber A; Bönner G; Hummerich W; Meurer KA; Kaufmann W
    Dtsch Med Wochenschr; 1980 May; 105(18):647-51. PubMed ID: 7371530
    [No Abstract]   [Full Text] [Related]  

  • 17. Amiloride in primary hyperaldosteronism with chronic peptic ulceration.
    Kremer D; Fraser R; Brown JJ; Lever AF; Davies DL; Robertson JI
    Br Med J; 1973 Apr; 2(5860):216-7. PubMed ID: 4700011
    [No Abstract]   [Full Text] [Related]  

  • 18. [Conn syndrome as cause of stubborn hypertension. Which hypertensives should you screen?].
    Reincke M
    MMW Fortschr Med; 2003 Feb; 145(9):37-40. PubMed ID: 12666528
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary aldosteronism: the most frequent form of secondary hypertension?
    Shargorodsky M; Zimlichman R
    Isr Med Assoc J; 2002 Jan; 4(1):32-3. PubMed ID: 11802308
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aldosteronism].
    Hofmann W; Kluge R
    Z Urol Nephrol; 1976 Mar; 69(3):219-22. PubMed ID: 961119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.